comparemela.com

Latest Breaking News On - Franck mouthon - Page 1 : comparemela.com

Theranexus : THERANEXUS ANNOUNCES APPOINTMENT OF MATHIEU CHARVÉRIAT AS BOARD OF DIRECTORS CHAIRMAN -March 11, 2024 at 03:05 am EDT

Theranexus : THERANEXUS ANNOUNCES APPOINTMENT OF MATHIEU CHARVÉRIAT AS BOARD OF DIRECTORS CHAIRMAN -March 11, 2024 at 03:05 am EDT
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

Haute normandieFrance generalMathieu charvFranck mouthonTheranexus boardExecutive chairmanEuronext growth

THERANEXUS ANNOUNCES APPOINTMENT OF MATHIEU CHARVÉRIAT AS BOARD OF DIRECTORS CHAIRMAN

THERANEXUS ANNOUNCES APPOINTMENT OF MATHIEU CHARVÉRIAT AS BOARD OF DIRECTORS CHAIRMAN
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

Haute normandieFrance generalMathieu charvStefan klotterFranck mouthonTheranexus boardExecutive chairmanEuronext growthLassen sie

Theranexus: CEO takes over as Chairman of the Board -March 11, 2024 at 08:22 am EDT

Theranexus, a biopharmaceutical company specializing in rare neurological diseases, announces the appointment of Mathieu Charvériat as Chairman of the Board of Directors, in addition to his current.

Mathieu charvFranck mouthonExecutive director

Lyon, France – 12 April 2023 – 6pm CEST – Theranexus, a biopharmaceutical company innovating in the treatment of rare neurological diseases and pioneer in the development of drug. | April 12, 2023

France generalUnited statesWorldsymposium orlandoMarco sardielloInserm transfertMathieu charvEmyr lloyd evansClaude bernard lyonResearch associationCardiff university united kingdomBaylor college of medicine houstonTranslational research conference for the managementAtomic energy commissionResearch tax creditFrench national institute of healthFederation of european neurosciences societies

THERANEXUS PUBLISHES ITS 2022 FULL-YEAR RESULTS AND PRESENTS AN UPDATE ON ITS PROGRAMS

Lyon, France - 12 April 2023 - 6pm CEST - Theranexus, a biopharmaceutical company innovating in the treatment of rare neurological diseases and pioneer in the development of drug candidates modulating

United statesFrance generalFlorence portejoieThierry lambertWorldsymposium orlandoMartin pierre laurentMarco sardielloMathieu charvEmyr lloyd evansInserm transfertClaude bernard lyonCardiff university united kingdomResearch associationFrench national institute of healthResearch tax creditFederation of european neurosciences societies

vimarsana © 2020. All Rights Reserved.